Key facts
- This page summarizes Susanne Fiedler's Form 4 filing for Organon & Co. (OGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 May 2024, 16:06.
Susanne Fiedler - 04 May 2024 Form 4 Insider Report for Organon & Co. (OGN)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- OGN
- Reported as of
- 04 May 2024
- Net transaction value
- -$31,160
- SEC form
- 4
- Accepted by SEC
- 07 May 2024, 16:06:49 UTC
- Prior SEC filing
- 03 Apr 2024
- Next SEC filing
- 05 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tarnetta V. Jones, as Attorney-in-Fact for Susanne Fiedler
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Susanne Fiedler filed Form 4 for Organon & Co. (OGN) on 07 May 2024.
Change
- Previous filing in this sequence was filed on 03 Apr 2024.
- Current net transaction value: -$31,160.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +4,989
- Change %
- +11%
- Price
- $0.000000
- Shares after
- 52,253
- Date
- 04 May 2024
- Ownership
- Direct
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $31,160
- Shares
- -1,589
- Change %
- -3%
- Price
- $19.61
- Shares after
- 50,664
- Date
- 04 May 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,989
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,989
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
Footnote F2
On each of May 4, 2022, May 4, 2023 and May 4, 2024, one-third of the RSUs vested.